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The amyloid precursor protein (APP)2 is an integral transmembrane glycoprotein that is highly expressed in the brain
and plays an important role in neuronal function (1). The
abnormal processing of APP to generate the amyloid ␤-peptide (A␤) leads to the extracellular neuritic plaques characteristic of Alzheimer disease (AD) (1–3). The rate of A␤
production is believed to be a key determinant of the onset
and progression of AD. Although proteolytic processing of
APP and characterization of the APP-cleaving enzymes (␣-,
␤-, and ␥-secretases) have revealed important targets for
drug discovery, the regulation of APP trafficking is less well
understood. Several recent findings support the idea that the
intracellular transport and subcellular localization of APP
are crucial determinants of APP processing and A␤ generation (4, 5). One pathway for A␤ generation involves the reinternalization of membrane-bound full-length APP (4, 5).
Endosomes have been shown to be intracellular compartments, where the sequential action of ␤- and ␥-secretases
generates amyloidogenic COOH-terminal fragments of APP
(APP-CTFs) and A␤ (1–3). APP is also targeted to and
degraded in the lysosomes (6). On the other hand, cleavage
within the A␤ region of APP by ␣-secretase, which prevents
the production of A␤, occurs in a late compartment of the
secretory pathway, such as the Golgi, or at the cell surface
(7). Deletion of the APP cytoplasmic tail or inhibition of
endocytosis has been shown to reduce A␤ levels, suggesting
that endocytosis is critical for A␤ generation (4, 5, 8). Understanding the mechanisms that regulate APP trafficking to
distinct subcellular compartments with the different secretase activities is important for developing strategies to
reduce abnormal processing and to prevent A␤-induced
neurotoxicity.
Numb is an evolutionarily conserved protein identified by
its ability to control cell fate in the nervous system of Dro2

The abbreviations used are: APP, amyloid precursor protein; A␤, amyloid
␤-peptide; AD, Alzheimer disease; APP-CTF, COOH-terminal fragment of
APP; PTB, phosphotyrosine binding domain; PRR, proline-rich region;
SPTB, short PTB; LPTB, long PTB; ELISA, enzyme-linked immunosorbent
assay; TFW, trophic factor withdrawal; PBS, phosphate-buffered saline;
Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; sAPP, soluble
APP; ANOVA, analysis of variance; TfR, transferrin receptor; E3, ubiquitinprotein isopeptide ligase; dyn, dynamin.
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Central to the pathogenesis of Alzheimer disease is the aberrant
processing of the amyloid precursor protein (APP) to generate
amyloid ␤-peptide (A␤), the principle component of amyloid
plaques. The cell fate determinant Numb is a phosphotyrosine
binding domain (PTB)-containing endocytic adapter protein that
interacts with the carboxyl-terminal domain of APP. The physiological relevance of this interaction is unknown. Mammals produce
four alternatively spliced variants of Numb that differ in the length
of their PTB and proline-rich region. In the current study, we
determined the influence of the four human Numb isoforms on the
intracellular trafficking and processing of APP. Stable expression
of Numb isoforms that differ in the PTB but not in the proline-rich
region results in marked differences in the sorting of APP to the
recycling and degradative pathways. Neural cells expressing Numb
isoforms that lack the insert in the PTB (short PTB (SPTB)) exhibited marked accumulation of APP in Rab5A-labeled early endosomal and recycling compartments, whereas those expressing isoforms with the insertion in the PTB (long PTB (LPTB)) exhibited
reduced amounts of cellular APP and its proteolytic derivatives
relative to parental control cells. Neither the activities of the ␤- and
␥-secretases nor the expression of APP mRNA were significantly
different in the stably transfected cells, suggesting that the differential effects of the Numb proteins on APP metabolism is likely to
be secondary to altered APP trafficking. In addition, the expression
of SPTB-Numb increases at the expense of LPTB-Numb in neuronal cultures subjected to stress, suggesting a role for Numb in
stress-induced A␤ production. Taken together, these results suggest distinct roles for the human Numb isoforms in APP metabolism and may provide a novel potential link between altered Numb
isoform expression and increased A␤ generation.

Distinct Roles of Numb Proteins in APP Metabolism

EXPERIMENTAL PROCEDURES
Antibodies and Reagents—Antibodies used for immunodetection of APP were 6E10 (anti-A␤ 1–17) and 22C11 (antisAPP␣) (Chemicon), anti-amino terminus of APP (2.F2.19B4;
SEPTEMBER 12, 2008 • VOLUME 283 • NUMBER 37

Chemicon), anti-carboxyl terminus of APP (APP 643– 695),
and 4G8 anti-A␤ (17–24) (Signet). The polyclonal antibodies to
Numb were obtained from Santa Cruz Biotechnology, Inc.
(Santa Cruz, CA) (sc-15590) or Upstate Biotechnology, Inc.
(anti-pan-Numb). The antibodies to Rab proteins were Rab5a
(Santa Cruz Biotechnology), Rab4a (Santa Cruz Biotechnology), Rab11 (Santa Cruz Biotechnology), and Rab7 (Sigma).
LAMP-1 antibody was from Santa Cruz Biotechnology. Antibodies to the following tags were GST (glutathione S-transferase; Cell Signaling), hemagglutinin epitope (Santa Cruz Biotechnology), and FLAG epitope (Cell Signaling). Other
antibodies included ERK1/2 and phospho-ERK1/2 (Cell Signaling), dynamin 1 (BD Biosciences), actin (Sigma), ubiquitin
(P4D1; Santa Cruz Biotechnology), transferrin receptor
(Zymed Laboratories Inc.), ␤-secretase 1 (BACE1; Sigma), presenilin-1 (PS1; Chemicon), nicastrin (Sigma), Aph-1 (Sigma),
and Pen-2 (Santa Cruz Biotechnology). Immunofluorescenceconjugated secondary antibodies (Alexa Fluor 488-conjugated
goat anti-mouse and Alexa Fluor 594-conjugated rabbit antigoat IgG) were obtained from Molecular Probes. Additional
reagents included Lipofectamine Plus reagent (Invitrogen),
FuGENE-6 (Roche Applied Science), EZ-Link Sulfo-NHSLC-Biotin (Pierce), (DAPT; Calbiochem), lactacystin, peptide
aldehyde N-carbobenzoxyl-l-leucinyl-l-leucinyl-l-leucinal
(MG-132), chloroquine (Calbiochem), and NH4Cl (Calbiochem). The ECL-Plus kit was obtained from Amersham Biosciences. The ␤-amyloid 1– 40 and 1– 42 colorimetric enzymelinked immunosorbent assay (ELISA) kit was purchased from
BIOSOURCE International Inc.
cDNA Constructs—Expression vectors for all four human
Numb isoforms have been described previously (28, 29). Fulllength Numb, PTB deletion mutants of human Numb, or control expression plasmids were constructed as in-frame fusions
downstream of the FLAG epitope. The plasmid for the dominant negative dynamin (dyn 1K44E tagged to hemagglutinin
and enhanced green fluorescent protein) (30) was a kind gift
from Dr. N. Bunnett (University of California, San Francisco,
CA). The cDNA encoding dyn 1K44E was subcloned into the
retroviral vector pBabe-puro (Addgene). The construct was
transfected together with a plasmid encoding the vesicular
stomatitis virus membrane glycoprotein envelope into 293T
packaging cells (Clontech) using FuGENE-6, and the resulting virus-containing supernatant was collected at 48 and
72 h after transfection and used for transduction as
described (31). Expression of exogenous dyn 1K44E was confirmed by immunoblotting.
Cell Lines and Transfections—PC12, HEK293, and SH-SY5Y
cells were cultured under standard conditions in Dulbecco’s
modified Eagle’s medium containing 10% fetal bovine serum
(Invitrogen) and maintained at 37 °C in a 5% CO2, 95% air
atmosphere (32, 33). The PC12 cells stably expressing Numb
variants have been described previously (28). SY5Y neuroblastoma cells stably transfected with a construct carrying the AD
disease-linked double (“Swedish”) mutation K595N/M596L in
APP were obtained from Dr. W. Araki (National Institute of
Neuroscience, Tokyo, Japan).
Treatments—Trophic factor withdrawal (TFW) was accomplished by washing the cells twice with phosphate-buffered
JOURNAL OF BIOLOGICAL CHEMISTRY
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sophila (11, 12). Numb contains two protein-protein interaction domains, a phosphotyrosine-binding domain (PTB)
and a proline-rich region (PRR) that functions as an Src
homology 3-binding domain (13, 14). Although only one
form of Numb has been identified in Drosophila, mammals
produce four alternatively spliced variants of Numb that differ in the length of their PTB (lacking or containing an 11-amino acid insert) and PRR (lacking or containing a 48-amino
acid insert) domains (13, 14). All Numb proteins contain the
NPF (asparagine-proline-phenylalanine) and DPF (aspartate-proline-phenylalanine) motifs that are critical for interaction with proteins containing the Eps15 homology domain
and with the clathrin protein AP-2, respectively. Numb can
associate with clathrin-coated pits, vesicles, and endosomes,
suggesting that it functions as an endocytic adapter protein
(15, 16). Numb plays a role in the internalization of receptors
that are involved not only in cell fate decisions during central
nervous system development (17) but also in neuronal maturation, differentiation, and survival (18, 19). Notch is an
evolutionarily conserved transmembrane receptor that specifies cell fate in a wide variety of tissues and organisms through
local cell-cell interaction (20). Numb regulates the endocytic
and ubiquitin-dependent processing of Notch (21) and consequently the cell fate decisions determined by Notch signaling
(22, 23). In maturing neurons, Numb binds to the neural adhesion protein L1 and integrin in axonal growth cones and promotes their recycling (24, 25).
Previous work has demonstrated an interaction between
APP and Numb in mouse brain lysates and in cell culture
(26). Truncation and site-directed mutagenesis studies have
shown that Numb binds to the YENPTY motif within the
intracellular domain of APP (26). Several other APP binding
partners that interact with this motif, including X11, Fe65,
mDab, C-Abl, and JIP-1, have been demonstrated to affect
endogenous APP localization and processing (27). Considering that Numb is an endocytic adapter protein, we determined whether expression of Numb influences the trafficking and processing of APP. Our results show that expression
of Numb isoforms lacking the insert in the PTB (short PTB
(SPTB)-Numb) caused the abnormal accumulation of cellular APP in the early endosomes and increased the levels of
APP-CTFs. By contrast, expression of the Numb isoforms
with the insert in PTB (long PTB (LPTB)-Numb) causes a
significant reduction in the cellular content of APP and APPCTFs. Interestingly, when cultured primary cortical neurons
were subjected to trophic factor deprivation, the expression
of the SPTB-Numb increased at the expense of LPTB-Numb,
suggesting that pathophysiological conditions can alter
Numb isoform expression in a manner that increases amyloidogenic processing of APP. Understanding the function of
Numb in the trafficking of APP may provide insights into the
regulation of APP processing in AD pathogenesis and lead to
possible AD therapies.

Distinct Roles of Numb Proteins in APP Metabolism
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Measurements of sAPP Levels—For detection of sAPP, the
media were collected from cultures of PC12 clones and centrifuged at 3,500 ⫻ g (10 min, 4 °C) to remove cell debris. The
cleared supernatants were concentrated at least 20-fold by
ultrafiltration. Cells were harvested, lysed, and prepared for
protein determinations. Equal amounts of volumes of supernatants, standardized to lysate protein, were subjected to SDSPAGE and immunoblotting analyses. All conditioned medium
values were normalized to total protein lysates.
A␤40/42 Sandwich ELISA—SH-SY5Y cells expressing the
Swedish mutant APP were transfected with plasmids for the
Numb variants or an empty pcDNA3 vector using Lipofectamine reagent according to the manufacturer’s specifications. Conditioned media from transfected cells were collected
48 h after transfection, and protein inhibitors and 4-(2-aminoethyl)-benzenesulfonyl fluoride (Sigma) were added to prevent
the degradation of A␤. The concentration of A␤40/42 in samples and standards was measured in duplicates using the
␤-amyloid 1– 40 and 1– 42 colorimetric ELISA kit according to
the manufacturer’s instructions (BIOSOURCE). Similar measurements of ␤-amyloid 1– 40 were performed in PC12 cells
subjected to TFW.
Measurements of Secretase Activity—The activity of APP
secretases was determined using commercially available secretase kits (R&D Systems) according to the manufacturer’s protocol. The method is based on the secretase-dependent cleavage of a secretase-specific peptide conjugated to the fluorescent
reporter molecules EDANS and DABCYL, which results in the
release of a fluorescent signal that can be detected using a fluorescence microplate reader (excitation at 355 nm/emission at
510 nm). The level of secretase enzymatic activity is proportional to the fluorimetric reaction.
Cell Surface Biotinylation—Confluent 10-cm dishes of each
of the PC12 clones were washed three times with ice-cold PBS
supplemented with 1 mM Ca2⫹ and 2 mM Mg2⫹ and incubated
with 1 ml of biotin label (Pierce EZ-Link Sulfo-NHS-Biotin) at 2
mg/ml for 0.5 h on ice in the dark on a rotary mixer. The reaction was stopped by extensive washing with PBS and quenched
with 50 mM glycine in PBS. Cell lysates were then immunoprecipitated with streptavidin-coated agarose. The precipitated
biotinylated proteins were subjected to immunoblotting to analyze the content of APP and transferrin receptor.
Statistical Analyses—Statistical comparisons were made by
using Student’s t test and ANOVA with Scheffe post hoc tests
for pairwise comparisons.

RESULTS
Expression of Numb Proteins Alters APP Metabolism in a
Manner Dependent upon the PTB—To investigate the impact
of Numb on APP metabolism, we stably overexpressed each of
the four human Numb proteins in PC12 cells (28, 29). APP is
physiologically processed by ␣-secretase or ␤-secretase, resulting in the shedding of nearly the entire ectodomain to yield
large soluble APP derivatives (called sAPP␣ and sAPP␤, respectively) and generation of membrane-tethered APP-CTFs that
include C83 and C99. The C99 is further cleaved by ␥-secretase
to release the ⬃4-kDa A␤ peptide and the APP intracellular
domain. Stable expression of the SPTB-Numb proteins resulted
VOLUME 283 • NUMBER 37 • SEPTEMBER 12, 2008
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saline (PBS) and then maintaining them in Locke’s buffer (29,
32). DAPT (2 M) was used to inhibit ␥-secretase activity. To
inhibit proteasomes and lysosomes, cells were treated with proteasomal inhibitors MG-132 (5 mol/liter) and clasto-lactacystin ␤-lactone (5 mol/liter) or the lysosomal inhibitors chloroquine (100 mol/liter) and NH4Cl (50 mmol/liter) for various
time periods. Inhibitors were resuspended either in DMSO or
PBS. Controls were treated either with equivalent volumes of
DMSO for the proteasome inhibitors or with equivalent volumes of PBS for chloroquine stimulations.
RNA Isolation and PCR—Total RNA from cells grown on
100-mm dishes was isolated with TRIzol (Invitrogen), and 2 g
of RNA was reverse transcribed with Superscript II reverse
transcriptase and an oligo(dT) primer (32, 33). Quantitative
real time PCR analyses of APP, Numb, and actin were performed using the following pairs of primers: rat APP, 5⬘-CCACTACCACAACTACCACTG-3⬘ (forward) and 5⬘-CCTCTCTTTGGCTTTCTGGAA-3⬘ (reverse); rat ␤-actin, 5⬘-TGTGATGGACTCCGGTGACGG-3⬘ (forward) and 5⬘-ACAGCTTCTCTTTGATGTCACGC-3⬘ (reverse); Rab5A, 5⬘-AACAAGACCCAACGGGCCAAATAC-3⬘ (forward) and 5⬘-ATACACAACTATGGCGGCTTGTGC-3⬘ (reverse); PTB-Numb, 5⬘-GGAAGTTCTTCAAAGGCTTCTTTG-3⬘ (forward) and PTB-Numb
5⬘-TTCATCCACAACTCTGAGTCCATC-3⬘ (reverse). The
Numb primers were designed to flank the alternatively spliced
insert in the PTB of the rat Numb cDNA sequence (accession
number NM_133287).
SDS-PAGE and Western Blotting—Cells were harvested and
lysed in buffer (100 mM Tris, pH 6.8, 1% SDS, 10 mM EDTA, 5
mM EGTA, 2 mM phenylmethylsulfonyl fluoride, 25 g/ml leupeptin, 5 g/ml pepstatin). The lysates were cleared by centrifugation at 13,000 ⫻ g for 20 min at 4 °C. The protein content of
cell lysates was measured using BCA reagent (Pierce). Extracts
containing 50 g of protein were electrophoresed using TrisHCl or 16.5% Tris-Tricine SDS-PAGE (Bio-Rad) under reducing conditions and immunoblotted onto nitrocellulose membranes (Bio-Rad). For immunodetection of blots, enhanced
chemiluminescence (ECL; Amersham Biosciences) was
applied. The optical band densities were quantified using NIH
Image Analysis software.
Immunofluorescence Microscopy—Following experimental
treatments, cells were fixed for 20 min in 4% paraformaldehyde
in PBS at room temperature, permeabilized (or not) with 0.2%
Triton X-100 in PBS, and incubated for 1 h in blocking solution
(0.2% Triton X-100, 5% normal horse or goat serum in PBS) and
then with primary antibody for 1 h in blocking solution at room
temperature (32, 33). The cells were washed with PBS and
finally incubated with 1 g/ml Alexa Fluor 488 goat anti-rabbit
IgG (1 g/ml; Molecular Probes) in blocking solution at room
temperature for 1 h. When double labeling was required, cell
preparations were incubated with Alexa Fluor 488-conjugated
anti-mouse IgG and rabbit Alexa Fluor 594-conjugated antigoat IgG (1:200). Immunostained cells were observed with the
appropriate filters on a Leica confocal laser-scanning microscope; average pixel intensity per cell was determined using
software supplied by the manufacturer. Appropriate controls,
such as secondary antibody alone, indicated a lack of nonspecific staining.

Distinct Roles of Numb Proteins in APP Metabolism

in a significant accumulation of intracellular APP (Fig. 1A) and
increased secretion of sAPP␣ and sAPP␤ in the conditioned
media (Fig. 1B). By densitometric scanning of Western blots,
the total amount of APP holoprotein in cells overexpressing the
SPTB-Numb proteins was increased by 4 –5-fold compared
with parental control cells and by 8 –10-fold compared with the
LPTB-Numb clones.
The intracellular accumulation of APP holoprotein coincided with a significant increase in the amount of APP processing products. Both total sAPP and the amount of sAPP␣ immunoprecipitated from the conditioned media with anti-APP
antibodies 22C11 and 6E10, respectively, were significantly
SEPTEMBER 12, 2008 • VOLUME 283 • NUMBER 37
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FIGURE 1. Isoform specificity in the processing of APP and generation of
A␤ by the Numb proteins. A, effect of Numb proteins on the amounts of APP
and TfR. Left, representative immunoblot showing total levels of APP and TfR
protein in the indicated PC12 clones. Each lane was loaded with 50 g of
protein. The relative amounts of APP and TfR were normalized to those of
actin. Densitometric analyses were performed on the immunoblots (right).
The values in the histogram represent the mean ⫾ S.D. n ⫽ 3; *, p ⬍ 0.01; #, p ⬍
0.05 (ANOVA with Scheffe post hoc tests) relative to empty vector-transfected
cells. B, effect of Numb proteins on the cleavage of APP. APP derivatives in the
conditioned medium and in lysates of the indicated PC12 clones were quantified by Western blot followed by densitometric analyses. APP derivatives in
conditioned culture medium were immunoprecipitated with an antibody to
the amino-terminal domain of the APP protein (22C11), which precipitates
both sAPP␣ and sAPP␤, and an antibody to A␤ (6E10; Signet), which recognizes sAPP␣. Steady-state levels of membrane-associated APP derivatives,
C99 and C83, were immunodetected with antibodies to the carboxyl-terminal
domain of the APP protein. The ␤-actin signal represents the internal loading
control. Densitometric analyses were performed on the immunoblots (left).
The values in the histogram represent the mean ⫾ S.D.; n ⫽ 3; *, p ⬍ 0.01;
#, p ⬍ 0.05 (ANOVA with Scheffe post hoc tests) relative to vector-transfected
control. Essentially similar results were obtained using two additional stable
clones. C, effect of Numb proteins on the generation of A␤ peptides. SY5Y
cells stably expressing the Swedish mutation of APP were transfected with
plasmids encoding the FLAG-Numb proteins. Conditioned media were harvested and analyzed by a sandwich ELISA for specific quantitation of A␤40
and A␤42. Expression of FLAG-Numb proteins was detected by immunoblotting using an antibody to FLAG (left). The histogram shows the amounts of
A␤40 and A␤42 in the indicated clones (right). The values represent the
mean ⫾ S.D.; n ⫽ 3; *, p ⬍ 0.01; #, p ⬍ 0.05 (ANOVA with Scheffe post hoc tests)
relative to vector-transfected cells.

higher in the SPTB-Numb clones. Steady-state levels of the
␣-secretase- and ␤-secretase-derived APP-CTFs, C83 and C99,
respectively, were also increased in lysates, consistent with the
ability of the SPTB-Numb proteins to promote nonamyloidogenic and amyloidogenic processing pathways (Fig. 1B). The
opposite effect was observed in the clones expressing LPTBNumb; steady state levels of APP holoprotein and APP processing products were markedly reduced relative to the parental
clones. Only with long exposure times could the sAPP and
APP-CTFs in the LPTB-Numb clones be detected. In contrast
to APP, no change in the total levels of the transferrin receptor
(TfR) (Fig. 1A) was found in the lysates, suggesting that the
observed effects mediated by the Numb proteins were selective
for APP. Collectively, the data indicate that the Numb proteins
that differ in the PTB affect the processing of APP in a distinct
and contrasting manner.
Expression of Numb Proteins Alters A␤ Generation in a Manner Dependent upon the PTB—Since the Numb proteins differentially affect APP cleavage and the generation of APP-CTFs,
we reasoned that Numb should also influence the generation of
A␤. To test this notion, the cDNAs encoding FLAG-Numb
variants were transfected into SY5Y cells expressing the Swedish mutant APP (Fig. 1C). A␤40 and A␤42 levels in the conditioned medium 48 h after transfection were determined using
ELISA measurements. Consistent with the observed effects
of Numb on the generation of APP-CTFs, we found that the
LPTB-Numb proteins suppressed the production of A␤40
and A␤42 into the conditioned medium, whereas cells
expressing the SPTB-Numb proteins generated elevated levels of A␤40 (7.3 versus 28.5 pg/ml/protein) and A␤42 (3.4
versus 13.2 pg/ml/protein) normalized to the total protein
amount (Fig. 1C).
Expression of the Numb Proteins Does Not Affect the Level of
APP Expression or the Proteolytic Activities of the APP-processing Secretases—One possible explanation for the effects of
Numb on APP metabolism would be an alteration in the
expression of APP. The presence of the Numb proteins had no
significant effect on the levels of APP mRNA (Fig. 2A). We also
considered the possibility that the Numb proteins might differentially alter the activities or the amounts of the APP-processing secretases. To investigate the influence of the Numb proteins on APP cleavages, we analyzed the proteolytic activities of
␣-, ␤-, and ␥-secretases using commercially available secretase
kits from R&D Systems. No significant difference in the proteolytic activities of these secretases was detected among the stable
clones (Fig. 2B). In addition, we found that levels of BACE1 and
of the ␥-secretase components (presenilin-1, nicastrin, APH-1,
and APH2) (34) were not altered by the expression of Numb
(Fig. 2C), which further argued against a role of the Numb proteins in regulating the proteolytic activities of the secretases.
Collectively, the data suggest that Numb proteins do not alter
APP metabolism by regulating the expression of APP or the
enzymatic activities of the secretases.
The Effects of Numb on APP Metabolism Are Dependent on Its
Interaction with APP and the Internalization of APP—Next, we
examined the interaction of the Numb proteins with APP to
determine whether isoform-specific interactions could explain
the contrasting effects of the Numb proteins on APP metabo-

Distinct Roles of Numb Proteins in APP Metabolism

lism. Purified GST-fusion proteins of APP were mixed with
lysates of 293 cells expressing a Numb protein isoform, and
pull-down assays were performed. We found no differences in
the ability of each Numb protein to interact with the APP protein (supplemental Fig. 1). Because the interaction of APP with
Numb requires the YENPTY motif interacting with the PTB
(26), we determined the effects of a Numb deletion mutant
lacking the PTB (⌬PTB-Numb) on APP metabolism. Quantification of the Western blots (normalized to actin) revealed that
APP metabolism was not altered in the presence of the ⌬PTBNumb protein (Fig. 3A), suggesting that the PTB is required for
the Numb proteins to influence APP metabolism. To determine
if the Numb proteins affect the proteolytic processing of APP by
targeting APP along the endocytic rather than the secretory
routes, we examined the effects of a dominant negative mutant
dynamin (dyn 1K44E tagged to the hemagglutinin epitope and
enhanced green fluorescent protein; a gift from N. Bunnett,
University of California, San Francisco, CA) on the ability of
each Numb protein to modulate APP metabolism. The GTPase
dynamin is an important mediator of clathrin-dependent endocytosis (35) and is required for the internalization of many cell
surface receptors including Notch (36) and APP (7). As

25496 JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 2. Lack of isoform specificity on the expression of APP and the
activities of the APP secretases. A, expression of the Numb proteins did not
alter the expression of APP. Left, semiquantitative real time PCR analysis of
APP mRNA in the indicated PC12 clones. The glyceraldehyde-3-phosphate
dehydrogenase signal represents the internal loading control. The values in
the histogram are the mean ⫾ S.D. of three independent measurements
(right). Essentially similar results were obtained using two additional stably
transfected clones. B, expression of the Numb proteins did not alter the activities of APP-processing secretases. The lysates were tested for secretase activities by the addition of secretase-specific peptide substrates conjugated to
the reporter molecules EDANS and DABCYL (R&D Systems). Fluorescently
labeled peptides were detected only upon cleavage by the respective secretases. After incubation at 37 °C for 2 h, reactions were transferred to a 96-well
plate, and fluorescence was measured as described under “Experimental Procedures.” The values expressed as arbitrary units of fluorescence (AUF) are the
mean ⫾ S.D. of at least three independent experiments. C, Numb proteins did
not alter the protein level of ␤-secretase (BACE1) and of the components of
the ␥-secretase complex. Representative immunoblots show total levels of
␤-secretase, presenilin-1, nicastrin, Aph-1, and Pen-2 in the indicated clones.
Each lane was loaded with 50 g of protein. Blots were reprobed with an
antibody against actin to confirm equal levels of protein loading among
samples.

expected, inhibition of endocytosis by mutant dynamin
induced an elevation of APP holoprotein in all of the clones,
including the LPTB-Numb clones (Fig. 3B). Total APP protein
level in the SPTB-Numb and LPTB-Numb clones was not significantly different compared with those in the vector-transfected and parental clones. These results indicate that the
Numb proteins differentially affect the processing of APP along
the endocytic route.
Numb Proteins Influence the Endosomal Trafficking of APP—
APP undergoes a retrograde transport back to the cell body
wherein it is localized in Rab5a-positive early endosomes (37),
late endosomes (8, 38), lysosomes (6), and the Golgi complex
(8). To determine whether the Numb proteins affect the transport of APP to these intracellular compartments, we applied
immunofluorescence microscopy to examine the subcellular
localization of APP and Numb. Both of these proteins are colocalized on the plasma membrane and in vesicular structures in
PC12 cells (Fig. 3C). Expression of the SPTB-Numb proteins
resulted in a marked accumulation of APP in enlarged endosomes (Fig. 3D) that were positively labeled for Rab5a (Fig. 3E).
Increased APP immunoreactivity was also detected in Rab11labeled recycling endosomes (data not shown) but not in
LAMP1-labeled lysosomal compartments of the SPTB-Numb
clones (data not shown). The subcellular location of APP was
similar to that of Numb, suggesting that Numb interacts with
APP in the early endocytic compartments. By contrast, APP
was only faintly detected in the Rab5-labeled (Fig. 3E),
Rab11-labeled, and LAMP1-labeled compartments (data not
shown) in LPTB-Numb clones. Collectively, these data suggest that the PTB of Numb determines the processing fates
of APP by regulating its endosomal sorting and trafficking to
distinct compartments.
Effect of the Numb Proteins on the Endosomal Sorting of APP
to the Recycling Pathway—Despite the accumulation of APP in
the enlarged early endosomes (Fig. 3D), SPTB-Numb clones
exhibited increased release of sAPP␣ and generation of C83,
suggesting that APP may be preferentially sorted from the early
endosomes back to the cell surface, where APP is cleaved by
␣-secretase. To evaluate the amount of APP localized on the
cell surface, we performed cell membrane staining for APP on
ice without permeabilization. Only a small fraction of APP was
detected at the cell surface of parental cells not permeabilized
prior to antibody incubation (Fig. 4A), consistent with a previous report (5). The fraction of cell surface-bound APP was
markedly higher in the SPTB-Numb clones. As expected, this
fraction was significantly lower in the LPTB-Numb clones
compared with parental cells. As another measure of surface
APP protein level, proteins on the cell surface were biotinylated
with a cell-impermeant cross-linker, collected with neutravidin-coupled beads, and subjected to immunoblotting. As
expected, the level of biotinylated plasma membrane-bound
APP was significantly higher in SPTB-Numb clones (Fig. 4C).
By densitometric scanning of Western blots, the amount of cell
surface-localized APP relative to TfR was approximately 5-fold
higher in cells overexpressing SPTB-Numb compared with vector-transfected cells (Fig. 4C). None of the biotinylated fractions contained actin consistent with the labeling of only cell
surface-bound proteins (Fig. 4B).

Distinct Roles of Numb Proteins in APP Metabolism

SEPTEMBER 12, 2008 • VOLUME 283 • NUMBER 37

JOURNAL OF BIOLOGICAL CHEMISTRY

25497

Downloaded from http://www.jbc.org/ at UCF Health Sciences Library on September 24, 2019

Effect of the Numb Proteins on the
Endosomal Sorting of APP to the
Degradative Pathway—To further
establish that altered subcellular
localization of APP is responsible
for the differences in its processing
fates in the Numb clones, we treated
PC12 clones with chloroquine, a
weak base known to disrupt lysosomal function by blocking organellar
acidification (42). Treatment with
chloroquine (100 M) for up to 6 h
(Fig. 5A) and longer (data not
shown) had no marked effects on
the levels of APP (Fig. 5A) and APPCTF derivatives (data not shown) in
SPTB-Numb clones. Similar results
were obtained in the presence of
ammonium chloride (NH4Cl; 50
mmol/liter), confirming that the
available pools of APP in the SPTBNumb cells were absent from the
FIGURE 3. Isoform specificity of Numb effects on APP metabolism is dependent on the interaction of the lysosomes (Fig. 5B). By contrast, levNumb proteins with APP and its subsequent internalization. A, expression of a Numb protein lacking the els of APP protein (Fig. 5A) and
PTB (⌬PTB-Numb) did not alter APP metabolism. Left, representative immunoblot showing total levels of APP
holoprotein in the indicated PC12 clones. Each lane was loaded with 50 g of protein. APP was quantified by APP-CTF derivatives (data not
Western blot with an antibody to the amino-terminal domain of the APP protein, followed by densitometric shown) in LPTB-Numb clones were
analyses (right). The relative amounts of APP were normalized to those of actin. B, inhibition of endocytosis by significantly increased following
overexpression of mutant dyn 1K44E abolished the effects of the Numb proteins on APP metabolism. Twentyfour hours after transduction, cell lysates were analyzed by immunoblotting, followed by densitometry (right). chloroquine treatment in compariA representative immunoblot shows total levels of APP in the indicated PC12 clones. Overexpression of the dyn son with vector-transfected cells,
1K44E was confirmed using antibodies raised to dyn 1 and to the hemagglutinin tag. The ␤-actin signal ruling out the possibility that chlorepresents the internal loading control. The values in the histogram represent the mean ⫾ S.D. n ⫽ 3; *, p ⬍ 0.01;
#, p ⬍ 0.05 (ANOVA with Scheffe post hoc tests) relative to vector-transfected cells. C, localization of APP and roquine at the concentration of 100
Numb in PC12 cells by confocal immunofluorescence microscopy. Following fixation and permeabilization, M was too low to induce APP accurabbit anti-Numb- and goat anti-rabbit-conjugated fluorescein isothiocyanate, mouse anti-APP (22C11), and
goat anti-mouse-conjugated CY3 secondary antibody were used to detect Numb and APP protein, respec- mulation in the SPTB-Numb clone
tively. The right panel shows the merged image of APP and Numb. D, intracellular accumulation of APP and (Fig. 5A). The same dose of chloromembrane-associated APP derivatives in a SPTB-Numb (left) and LPTB-Numb clone (right). Following fixation quine also caused marked accumuand permeabilization, APP was detected with antibodies to the amino- and carboxyl-terminal domains of the
APP protein. E, localization of APP to endocytic compartments by confocal immunofluorescence microscopy. lation of APP and APP-CTFs in
Following fixation and permeabilization, rabbit anti-Rab5A and goat anti-rabbit conjugated fluorescein iso- SH-SY5Y cells stably transfected
thiocyanate were used to detect the early endosomes (green signal), and mouse anti-APP (22C11) and goat
with the empty vector or with the
anti-mouse-conjugated CY3 secondary antibody were used to detect APP protein (red signal). The right side of
each image shows the merged image of APP and Rab5, depicting early endosomes. The images are represent- Swedish mutant APP (Fig. 5C). The
ative of those obtained from at least three stably transfected clones.
effect of lysosomal inhibitors on
APP protein levels was dosedependent (data not shown). ConTo determine whether vesicle recycling contributed to the trol incubation of PC12 clones with PBS resulted in unchanged
increased cell surface expression of APP in the SPTB-Numb levels of APP (data not shown). To determine that the chloroclone, we assessed the impact of a blockade in the endosome quine-induced increase in APP holoprotein was not related to
recycling pathway. Preincubation with monesin, an established an effect of Numb on the synthesis of APP, we treated cells with
inhibitor of the recycling pathway that does not interfere with the protein synthesis blocker cycloheximide (10 g/ml) in comthe initial endocytosis of surface receptor proteins (43), signif- bination with chloroquine. Treatment with cycloheximide for
icantly depleted cell surface APP expression, as assessed by sur- 6 h did not prevent the chloroquine-induced increase in APP
face biotinylation followed by immunoblotting of the isolated holoprotein (data not shown).
biotinylated fraction (Fig. 4D). The surface receptor-depleting
In contrast to lysosomal inhibitors, we found that treatment
effect of monesin on TfR was only slightly reduced in the with the ␥-secretase inhibitor DAPT markedly enhanced
absence of ligand (Fig. 4D), suggesting that the recycling path- steady state levels of APP and APP-CTFs in the SPTB-Numb
way of APP may be mechanistically distinct from that of TfR. clone (Fig. 5D). The APP-CTFs were only weakly detected in
Quantification of the immunoblots revealed that the changes in the vector cells but became clearly visible, as in the untreated
the ratio of APP to TfR after treatment with monesin was sig- SPTB-Numb clones, after treatment with DAPT, which halted
nificantly greater in the SPTB-Numb clone compared with the the cleavage of membrane-associated APP-CTFs. The effect of
vector-transfected cells (Fig. 4E).
DAPT on APP protein levels was dose-dependent (data not
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protein species in general, as
shown in Western blot analysis
conducted with an antibody to
ubiquitin (data not shown). Collectively, the data indicate that the
drastic reduction in APP protein
level in the LPTB-Numb clones
was not due to Numb-mediated
targeting of APP for proteasomedependent degradation.
Expression of Numb Proteins
Alters the Levels of the Rab Family of
Endocytic Regulators—Recent studies have demonstrated the involvement of GTP-binding proteins of
the Rab family in the trafficking and
processing of APP (44, 45). Rab proteins are localized in both discrete
organelles and vesicles, where they
play key roles in protein trafficking
FIGURE 4. Effect of the Numb proteins on the sorting of APP to the recycling pathway. A, the Numb
proteins differentially alter the amount of cell surface APP. Immunostaining of cell surface APP with an anti- between compartments along the
body to the amino-terminal end of APP is shown. In nonpermeabilized cells (without Triton X-100), significantly secretory and endocytic routes. To
more APP is detected on the surface of a SPTB-Numb clone compared with a LPTB-Numb clone or a clone determine whether the differential
transfected with empty vector. B, detection of cell surface APP by biotinylation. Cells were surface-biotinylated,
lysed, and incubated with streptavidin-agarose beads. Biotinylated proteins were immunoblotted with anti- endosomal sorting of APP resulted
bodies to APP and TfR. C, quantitative data showing the ratio of cell surface APP and TfR in the indicated clones. from the altered expression of Rab
Values are the mean ⫾ S.D. of at least three independent experiments. *, p ⬍ 0.01; #, p ⬍ 0.05 (ANOVA with
Scheffe post hoc tests) relative to vector-transfected cells. D, recycling blockade depletes cell surface APP proteins, we measured protein levprotein level. The indicated clones were pretreated with monensin for 60 min at 37 °C in Dulbecco’s modified els of Rab4, Rab5A, Rab7, and
Eagle’s medium/bovine serum albumin and incubated in Dulbecco’s modified Eagle’s medium/bovine serum Rab11. Rab5A is a small GTPase
albumin for 60 min afterward. Cells were then surface-biotinylated using a membrane-impermeable crosslinker and immunoprecipitated with streptavidin beads. Precipitates were subjected to SDS-PAGE, and blots localized on early endosomes and
were probed with antibodies to APP and TfR. E, quantitative data showing the changes in the ratio of cell controls endosome fusion along the
surface APP and TfR in the vector-transfected and a SPTB-Numb clone after monesin treatment. Values are
endocytic pathway. Rab4A and
plotted as percentage of untreated control (vehicle) and are the mean ⫾ S.D. of at least three independent
Rab11 are regulators of the recyexperiments. *, p ⬍ 0.05 (Student’s t test) relative to vector-transfected cells.
cling endosomes (44, 45). Protein
shown). In contrast, DAPT failed to elevate levels of APP-CTFs levels of Rab4A, Rab5A, and Rab11 were significantly increased
in the LPTB-Numb clones. Collectively, our data indicate that in the SPTB-Numb clones relative to control cells (Fig. 6, A and
the Numb proteins target APP to endocytic compartments with B). By contrast, levels of Rab5A and Rab11 were decreased in
the LPTB-Numb clones relative to control cells (Fig. 6, A and
distinct APP processing outcomes.
The Proteasome-mediated Degradative Pathway Is Not B). Levels of Rab7, a regulator of fusion events in the late endoInvolved in the Regulation of APP Metabolism by the Numb cytic pathway, and of LAMP-1 (lysosome-associated memProteins—Considerable evidence indicates that Numb antago- brane protein-1) were not different among the stable clones
nizes Notch signaling transduction by activating the endocytic (Fig. 6, A and B). The changes in the level of the Rab5A protein
uptake and degradation of the Notch protein via the proteaso- were not attributable to altered expression, since its mRNA
mal degradation pathway (21, 40). Because of the striking sim- level was not significantly different in the stably transfected
ilarities in the proteolytic processing of Notch and APP, we Numb clones (Fig. 6C).
Stress Induces the Selective Up-regulation of SPTB-Numb
hypothesized that the LPTB-Numb proteins may reduce APP
protein levels by facilitating proteasomal-mediated degrada- Transcripts—It has been previously reported that alternative
tion of APP. To test this hypothesis, we treated the stable clones splicing of Numb primary transcripts is developmentally reguwith lactacystin, which inhibits proteasomal degradation of lated (45, 46). To determine whether the balance of the alternaproteins by specifically targeting the 20 S proteasome, without tive spliced variants of Numb might be disrupted in cells that
interfering with lysosomal protein degradation (41). Treatment were stimulated by apoptosis-inducing agents, we designed oliwith lactacystin did not result in significant changes in APP gonucleotide primers that bind to the flanking sequences of the
protein levels and did not impact the generation of APP metab- insertion in the PTB (Fig. 7A). The expected sizes of the ampliolites in any of the clones tested (Fig. 5E), suggesting that the fied PCR products for the SPTB- and LPTB-Numb transcripts
differential effects of the Numb proteins on APP metabolism were 114 and 147 base pairs, respectively. The level of LPTBdid not involve the ubiquitin-proteasome protein degradation Numb mRNA that is predominantly expressed under basal
pathway. Higher concentrations of lactacystin did not signif- condition decreased rapidly upon TFW, an insult that has preicantly induce APP accumulation, although the dose of 10 viously been shown to alter Numb expression (29), whereas that
M was sufficient to induce enrichment of ubiquitinated of SPTB-Numb accumulated concomitantly in stressed cells
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endocytosis and endosome recycling. A␤ immunoreactivity is evident in these populations of
enlarged endosomes prior to A␤
deposition indicating their potential
importance for A␤ formation in
early AD brain. Much attention has
focused on the mechanisms that
regulate the trafficking of APP to
endosomes. In this study, we have
uncovered a novel function for the
Numb adapter proteins as a regulator of endocytic trafficking of APP.
Most surprisingly, we found that the
Numb proteins that differ in the
PTB, but not in the PRR domain,
have opposite effects on the transport and processing of APP. The
expression of SPTB-Numb proteins
resulted in a significant accumulation and persistence of APP holoprotein in the early endosomes and
increased A␤ secretion. By contrast,
expression
of LPTB-Numb proteins
FIGURE 5. Effect of the Numb proteins on the sorting of APP to the degradative pathway. A, time course of
the accumulation of APP and APP-CTFs in LPTB-Numb but not SPTB-Numb clones after treatment with a significantly decreased the accumulysosomal inhibitor. The indicated stable PC12 clones were treated with choroquine (100 M) for 0, 2, and 6 h.
Equal amounts of cellular lysates were separated by 16.5% Tris-Tricine SDS-PAGE and immunoblotted with an lation of APP and inhibits A␤ secreantibody to the carboxyl terminus of APP. ␤-Actin was used as the internal loading control. Densitometric tion. The reduction in A␤ secretion
analyses were performed on the immunoblots (bottom). The values in the histogram are the mean ⫾ S.D. of was not the result of either the
three independent measurements. *, p ⬍ 0.01; #, p ⬍ 0.05 (ANOVA with Scheffe post hoc tests) relative to
vector-transfected cells. Similar results were obtained using two additional stably transfected Numb clones. decreased expression of APP or a
B, time course of the accumulation of APP in LPTB-Numb but not SPTB-Numb clones upon treatment with significant reduction in the activiNH4Cl. The indicated clones were treated with NH4Cl (50 M) for 0, 2, 6, and 8 h and processed for immunoties of the APP processing secretablotting using an antibody to the carboxyl-terminal of APP. C, time course of the accumulation of APP and
APP-CTFs in SH-SY5Y cells overexpressing the empty vector (Vector) or a vector encoding the Swedish mutant ses. Furthermore, we demonstrated
APP (APP) upon chloroquine treatment. The indicated SY-SY5Y clones were treated with choroquine (100 M) that all the Numb isoforms were
for 0, 2, and 6 h. Each lane was loaded with 50 g of protein. ␤-Actin was used as the internal loading control.
D, time course of the accumulation of APP in the SPTB-Numb but not LPTB-Numb clones after treatment with capable of interacting with the APP
the ␥-secretase inhibitor DAPT. The indicated clones were treated for 0, 2, 6, and 12 h with 10 M DAPT. Each holoprotein, as reported by a previlane was loaded with 50 g of protein. ␤-Actin was used as the internal loading control. Densitometric analyses ous study (26). The APP-lowering
were performed on the immunoblots (bottom). Values are the means ⫾ S.D. of three independent measurements. *, p ⬍ 0.01 (ANOVA with Scheffe post hoc tests) relative to empty vector-transfected cells. E, inhibition of effect was related to the trafficking
the proteasomes failed to affect the regulation of APP metabolism by the Numb proteins. Time course of the role of the LPTB-Numb proteins
levels of APP and APP-CTFs in the indicated clones after treatment with 10 M lactacystin. Equal amounts of
protein from each sample were immunoblotted to detect APP and APP-CTFs. Each lane was loaded with 50 g along the endocytic rather than the
of protein and verified with an antibody to actin. Essentially similar results were obtained using two additional secretory pathway as treatment
stably transfected Numb clones.
with lysosomal inhibitors was able
to restore endogenous APP holo(Figs. 7, B and C). Protein but not mRNA levels of APP were also protein to the steady state level found in vector-transfected
increased in PC12 cells subjected to TFW (Fig. 7D). TFW mark- cells. It is conceivable that LPTB-Numb but not SPTB-Numb
edly increased the production of A␤ 1– 40 (Fig. 7E). Collec- proteins facilitate the delivery of APP to the lysosomes for degtively, these data suggest that cellular stress could induce the radation by acidic hydrolases. Taken together, these results
selective up-regulation of SPTB-Numb proteins, which pre- indicate that APP trafficking differs strikingly in the clones stacedes the accumulation of APP protein. The stress-induced bly expressing the Numb proteins and raise the intriguing poschanges in Numb isoform expression and the subsequent sibility that alternative splicing of Numb could alter the trafNumb isoform-dependent effect on APP trafficking and proc- ficking of APP and, concomitantly, its processing fate.
Numb was discovered as an intracellular Notch antagonist
essing are schematically summarized in Fig. 8.
(17, 19). Considerable evidence over the past years has indiDISCUSSION
cated that Numb antagonizes Notch1 signaling by inducing
Alterations in the endosomal-lysosomal system are believed Notch1 ubiquitination and endocytic degradation of NICD (21,
to occur early in the disease process in AD, and may precede the 41). Genetic and biochemical evidence in invertebrates has sugformation of plaques and tangle-associated neuropathology in gested that proteasomal degradation of Notch may be required
susceptible neuron populations. Endosome enlargement for the cessation of Notch signaling (21, 41). Numb has been
occurs early in sporadic AD, and is associated with increased shown to recruit the E3 ubiquitin ligase to facilitate Notch
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receptor ubiquitination (21). Several E3 ubiquitin ligases, such
as LNX, Itch, Siah1, and Mdm2, have been shown to associate
with Numb (21, 47– 49). To exclude the possibility that LPTBNumb targets APP for proteasomal degradation, we found that
proteasomal inhibition had no marked effect on the accumulation of APP in the stable clones examined, suggesting that
Numb did not target APP for proteasomal degradation.
The PTB is a protein-protein interaction motif that has been
identified in a diverse group of proteins, of which only a subset
is linked to tyrosine kinase-mediated signaling (50). Structurefunction analyses indicated that the Numb PTB can bind to
multiple conformationally distinct peptide ligands in a phosphotyrosine-independent manner (51–53). The PTB of Numb
has been shown to interact with diverse proteins that determine
its subcellular localization (54) and protein stability (55). The
PTB of Numb mediates the interaction with the E3 ubiquitin
ligases responsible for the ubiquitination of its bound substrates, such as Notch and Gli (17, 21). Hence, the presence or
absence of the insertion within the PTB could impact the interaction of the Numb proteins with E3 ligases and the targeted
substrates (17, 56). We found that the insert in the PTB did not
affect the ability of the Numb proteins to interact with APP, in
accord with a previous study showing that APP was found in
complex with all four mammalian Numb isoforms in cortical
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FIGURE 6. Effect of the Numb proteins on the levels of small Rab GTPases.
A, representative immunoblots showing total amounts of Rab4A, Rab5A,
Rab7, Rab11, and LAMP1 in the indicated clones. Each lane was loaded with
50 g of protein and verified with an antibody to actin. B, densitometric analyses were performed on the immunoblots shown in A. The values in the histogram are the mean ⫾ S.D. of three independent measurements. *, p ⬍ 0.01;
#, p ⬍ 0.05 (ANOVA with Scheffe post hoc tests). C, semiquantitative real time
PCR analysis of Rab5A mRNA in the indicated PC12 clones. The glyceraldehyde-3-phosphate dehydrogenase signal represents the internal loading
control.

lysates (26). Furthermore, the insert of the PTB did not alter the
subcellular localization of the Numb proteins (28, 29), suggesting that the differential effects of the Numb proteins on APP
metabolism could not be attributed to the preferential targeting
of LPTB-Numb proteins to membrane-bound APP. The present study showed that Numb can bind directly to the YENPTY
motif in the cytoplasmic domain of APP (supplemental Fig. 1),
an interaction that is not only required for the internalization of
cell surface APP but also for its subsequent transport and processing fate (57).
The accumulation of APP holoprotein did not correlate with
a reduction of A␤ secretion, which supports the contention that
the Numb proteins influence the trafficking of endogenous
APP along endocytic rather than secretory routes. Additional
data showed that inhibition of endocytosis by overexpression of
a dominant-negative dynamin negates the observed effects of
the Numb proteins on APP metabolism. Furthermore, treatment of the Numb clones with brefeldin A to inhibit the transport of proteins from the endoplasmic reticulum to the Golgi
did not show any effect on APP accumulation (data not shown),
whereas lysosomal inhibitors restored steady state levels of APP
in the LPTB-Numb clones (Fig. 5).
The reduced sensitivity of the SPTB-Numb clones to inhibition of lysosomal degradation suggests that these Numb proteins may interfere with the transport of APP to the degradative
pathway. Alternatively, we cannot rule out the possibility that
these Numb proteins play an active role in recycling internalized APP back to the cell surface. This notion is consistent with
the increased amounts of released sAPP␣ and intracellular C83
generated by ␣-secretase cleavage, which occurs mainly at the
cell surface. Since dissociation of protein-protein complexes
favors the recycling pathway, it remains to be elucidated
whether the interaction of the Numb proteins and APP results
in conformational changes that are differentially resistant to
decreasing pH values within the endosomal pathway. Regardless of the underlying molecular mechanisms, our data suggest
that the Numb proteins differentially alter the endocytic trafficking of APP by regulating the endosomal sorting of this protein either to the degradative or recycling pathway. It will be
interesting to examine whether the Numb proteins differentially affect the trafficking of other receptors with the conserved
YENPTY motif, such as TrkA, a tyrosine kinase receptor whose
protein level and responsiveness to nerve growth factor were
shown to be differentially affected by the Numb proteins (28).
Whether the Numb proteins are directly involved in the
active transport of APP remains to be elucidated. Intracellular
trafficking through the endocytic and recycling pathway is regulated by the small GTPase Rab proteins, whose altered expression and activity has been linked to altered APP metabolism (9,
10, 44). Rab5A up-regulation is associated with enlarged early
endosomes and intracellular accumulation of APP (9). Altered
Rab5A activity is responsible for the early abnormalities of the
neuronal endocytic pathway that are directly related to a rise in
A␤ levels in the brains of AD patients (9, 10). Previous studies
demonstrated that Numb interacts with Arf6 and EHD4 (58),
proteins that have been associated with the recycling of plasma
membrane proteins internalized by clathrin-dependent and
clathrin-independent endocytic routes (59). Impairments in
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FIGURE 8. Summary diagram showing the effects of the alternatively spliced Numb isoforms on the
trafficking and processing of APP.

SEPTEMBER 12, 2008 • VOLUME 283 • NUMBER 37

JOURNAL OF BIOLOGICAL CHEMISTRY

25501

Downloaded from http://www.jbc.org/ at UCF Health Sciences Library on September 24, 2019

FIGURE 7. Detection of alternatively spliced Numb transcripts under normal and stressed conditions.
A, domain structure of the Numb protein. The 11-amino acid insertion in the PTB is indicated in black. The
forward (F) and reverse (R) primers were designed to amplify a region flanking the PTB insertion. The
specificity of the primer set was confirmed by performing PCR using an empty plasmid (pCDNA3.1) or
plasmids containing each of the four Numb isoforms. The expected sizes of PCR fragments were 114 and
147 base pairs for the SPTB- and LPTB-Numb transcripts, respectively. B, time course of SPTB-Numb and
LPTB-Numb mRNA levels in PC12 cells subjected to TFW. C, densitometric analyses were performed on the
data shown B. The values in the histogram are the mean ⫾ S.D. of three independent measurements. *, p ⬍
0.01 (Student’s t test) relative to untreated control PC12 cells. D, effect of stress-induced Numb isoform
change on APP processing. Top, semiquantitative real time PCR analysis of APP mRNA levels in PC12
before and after TFW for the indicated times. The glyceraldehyde-3-phosphate dehydrogenase signal
represents the internal loading control. Bottom, representative immunoblots showing total levels of APP
in PC12 cells left untreated (Con) or subjected to TFW for 24 h. Each lane was loaded with 50 g of protein.
␤-Actin was used as the internal loading control. Densitometric analyses were performed on the immunoblots. The values in the histogram represent the mean ⫾ S.D. of three independent measurements.
*, p ⬍ 0.05 (Student’s t test) relative to nontreated cells. E, effect of stress-induced Numb isoform change
on the generation of A␤. PC12 cells were left untreated (Con) or subjected to TFW for 24 h. Conditioned
media were harvested and analyzed by a sandwich ELISA for specific quantitation of A␤40. The histogram
shows the relative amounts of A␤40. The values represent the mean ⫾ S.D.; n ⫽ 3; *, p ⬍ 0.01 (Student’s t
test) relative to nontreated control cells.

the sorting pathway could also
account for the intraneuronal A␤
accumulation in the brains of APP
mutant transgenic mice and
human AD patients (60). We
found that level of Rab5A protein
but not mRNA was elevated in the
SPTB-Numb clones, suggesting
that altered Rab5A function in
part correlates specifically with
altered trafficking of APP. The
mechanism(s) whereby expression
of SPTB-Numb increases protein
level of Rab5A but not mRNA
remains to be established.
At present, the factors that regulate the alternative splicing of the
primary Numb transcript are not
known. It has been shown that the
four Numb isoforms are temporally
regulated and implement distinct
developmental functions (45, 46).
Ectopic expression of Numb isoforms lacking the PRR insertion
promotes differentiation, whereas
those isoforms with the insertion
direct proliferation. Indeed, the
expression of LPRR-Numb isoforms
that promote proliferation peaks
during the expansion of the neural
progenitor pool but is down-regulated during the course of neuronal
development (45, 46). The expression pattern of the Numb proteins
also varies dramatically between
different tissues and cultured cell
lines, suggesting that Numb isoforms may have different functions
in different cell types. Our previous
study demonstrated that Numb
protein levels increased in A␤-laden
brain regions of a mouse model of
AD (29). In this study, we found for
the first time that pathophysiological conditions can up-regulate the
expression of SPTB-Numb at the
expense of LPTB-Numb. This finding raises the intriguing possibility
that altered Numb expression is an
early pathologic event that may be
responsible for increased A␤ production in patients with AD.
Although the exact function of
APP is still not resolved, experimental evidence suggests several activities, including synaptogenesis, neurite outgrowth, and cell survival in
neurons (1). All of these activities
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may potentially be affected by the presence of Numb proteins
determining the processing fates of APP. Of particular note is
that overexpression of SPTB-Numb in PC12 cells enhanced
neurite outgrowth (28) and increased vulnerability to apoptotic
stimuli by a mechanism dependent on the dysregulation of
intracellular Ca2⫹ homeostasis (28, 29). How Numb modulates
intracellular Ca2⫹ homeostasis remains to be elucidated. The
disruption in Ca2⫹ signaling may be linked to altered APP
metabolism (1, 39), suggesting the involvement of altered
Numb function or expression in the genesis of the AD phenotype. Hence, perturbation of Numb expression may have
important implications for AD pathogenesis.
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